Lancet, 402(10403), 720-730
Injectable BPC-157 Injecting BPC-157 subcutaneously (SubQ) or intramuscularly (IM) bypasses the digestive system and allows for systemic absorption , delivering the peptide into the bloodstream to reach injured tissues throughout the body
Most providers recommend remaining on semaglutide for at least 12 to 18 months during active weight loss, then transitioning to a maintenance dose rather than stopping entirely
Semaglutide and Tirzepatide are part of a class of medications known as GLP-1 Agonists also known as GLP-1 Peptides
You may find that you need hydrating products at this stage to combat the dryness that comes with curly hair
If you experience severe abdominal pain, persistent vomiting, or signs of dehydration at any point, contact your provider as soon as you can